Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review

“This review revealed 29 primary risk factors associated with arm morbidity after breast cancer treatment.” Credit: 2023 Klein et al. “This review revealed 29 primary risk factors associated with arm morbidity after breast cancer treatment.” BUFFALO, NY- December 11, 2023 – A new review paper was published in Oncotarget’s Volume 14 on December 1, 2023, […]

Dec 11, 2023 - 18:00

Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review

“This review revealed 29 primary risk factors associated with arm morbidity after breast cancer treatment.”

Oncotarget

Credit: 2023 Klein et al.

“This review revealed 29 primary risk factors associated with arm morbidity after breast cancer treatment.”

BUFFALO, NY- December 11, 2023 – A new review paper was published in Oncotarget’s Volume 14 on December 1, 2023, entitled, “Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review.”

In this review, researchers Ifat Klein, Michael Friger, Merav Ben David, and Danit Shahar from Assuta Medical Center and Ben-Gurion University of the Negev in Israel aimed to examine the risk factors for arm morbidity following breast cancer treatments. The team took a broad view of all types of physical morbidity, including prolonged pain, lymphedema, decreased range of motion, and functional limitations.

“A systematic literature review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Guidelines.”

Studies exploring the risk factors for prolonged arm morbidity following breast cancer surgery and treatments were included. The studies were assessed independently according to pre-eligibility criteria, following data extraction and methodological quality assessment. 1,242 articles were identified. After removing duplicates, the full texts of 1,153 articles were examined. Sixty-nine of these articles met the criteria and were included in the review.

These 69 articles identified 29 risk factors for arm morbidity following treatments for breast cancer. The risk of bias was evaluated using NIH study quality assessment tools. The studies reviewed were published between 2001 and 2021 and included a total of 22,886 patients who were followed up for between three months and 10 years. The main risk factors for long-term morbidity are removal of lymph nodes from the axilla, body mass index >30, having undergone a mastectomy, the stage of the disease, radiation therapy, chemotherapy, infection and trauma to the affected arm after surgery.

“An understanding of the risk factors for prolonged arm morbidity after surgery can help doctors and therapists in making personalized decisions about the need and timing of rehabilitation treatments.”

Read the full paper: DOI: https://doi.org/10.18632/oncotarget.28539

Correspondence to: Ifat Klein

Email: ifatgoldberg@hotmail.com

Keywords: risk factors, arm morbidity, physical rehabilitation, breast cancer

About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media: